3 results

• Eli Lilly Claims Kisunla Brain Swelling Side Effects Can Be Reduced With Modified Dosing Schedule

  November 4, 2024

  Irvin Jackson

  Makers of the new Alzheimer's disease drug Kisunla have developed a new dosing schedule, which may reduce the risk of brain swelling.

• Eisai Never Told Patients in Leqembi Clinical Trials They Faced Higher Risk of Brain Bleeds: NYT

  October 25, 2024

  Martha Garcia

  New York Times investigative report reveals that the manufacturer of the Alzheimer’s disease drug Leqembi failed to inform test subjects that they had genetic markers making them more susceptible to brain bleeds and death if they took the medication.

• Aricept Recall Petition Filed by Public Citizen for High-Dose Version

  May 20, 2011

  Staff Writers

  The prominent consumer watchdog Public Citizen is calling for a recall of Aricept 23 milligram, arguing that the higher dose...